Trillium Therapeutics Inc.
Trillium Therapeutics Inc. (TRIL) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 55 transactions totaling $2.5M, demonstrating a bearish sentiment with -$2.5M in net insider flow. The most recent transaction on Nov 17, 2021 involved a transaction of 75 shares valued at $0.
TRIL Insider Activity Summary
Who Is Buying TRIL Stock?
No significant insider buying has been recorded for TRIL in the recent period.
Who Is Selling TRIL Stock?
No significant insider selling has been recorded for TRIL in the recent period.
Is Trillium Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TRIL is bearish with an Insider Alignment Score of 0/100 and a net flow of -$2.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
TRIL Frequently Asked Questions
Understanding TRIL Insider Activity
Insider trading at Trillium Therapeutics Inc. (TRIL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading TRIL stock, having executed 55 transactions in the past 90 days. The most active insider is Jan Skvarka (Executive), who has made 9 transactions totaling $1.6M.
Related Tools
Track Trillium Therapeutics Inc. Insider Activity
Get notified when executives and directors at TRIL file new Form 4 transactions